Award
BPA Call #75F40126F19012
Deloitte Consulting Awarded BPA Call for Drug Labeling Initiative Support
Buyer
Food and Drug Administration
Award Amount
$5,692,681.70
Ceiling
$5,692,681.70
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2027
Identifier
75F40126F19012
NAICS
541990
This contract represents a Blanket Purchase Agreement (BPA) call awarded to Deloitte Consulting LLP, building upon a multi-year BPA focused on the Drug Labeling Initiative. Deloitte, a prominent consulting firm with expertise in health and government services, is tasked with providing critical support to the FDA’s Center for Drug Evaluation and Research (CDER) to enhance drug labeling compliance and safety. The contract covers specialized services aimed at improving the accuracy and clarity of drug labels, thereby benefiting public health and ensuring adherence to regulatory standards. Awarded through a competitive bidding process, this call is part of an ongoing multi-year engagement that advances the initiative’s goals established under the overarching BPA. The work will be performed primarily in Silver Spring, Maryland, with key deliverables scheduled over a one-year period. This contract reinforces the agency’s commitment to elevating drug safety through improved labeling practices.
Description
DRUG LABELING INITIATIVE - CDER SUPPORT